--- title: "Promising Pharmaceutical Stocks To Keep An Eye On - August 22nd" type: "News" locale: "en" url: "https://longbridge.com/en/news/296686524.md" description: "MarketBeat's stock screener identifies seven pharmaceutical stocks to watch on August 22nd: Eli Lilly, Merck & Co., Johnson & Johnson, AbbVie, McKesson, Abbott Laboratories, and Pfizer. These companies were selected based on having the highest dollar trading volume among pharmaceutical stocks in recent days. The report highlights their business segments and key products while noting potential growth opportunities and risks associated with clinical trials and regulatory decisions." datetime: "2026-08-22T18:01:44.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296686524.md) - [en](https://longbridge.com/en/news/296686524.md) - [zh-HK](https://longbridge.com/zh-HK/news/296686524.md) generator: "portal-rs" --- # Promising Pharmaceutical Stocks To Keep An Eye On - August 22nd - 2 Biotech Stocks Shaping Up for Major Breakouts Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson, AbbVie, McKesson, Abbott Laboratories, and Pfizer are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of companies that research, develop, manufacture, and sell prescription drugs, vaccines, and other medical treatments. For investors, these stocks may offer growth potential from successful products and drug approvals, but they can also carry risks related to clinical-trial results, regulatory decisions, patent expirations, pricing pressures, and competition. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days. Get **Eli Lilly and Company** alerts: ## Eli Lilly and Company (LLY) Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. - The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic Read Our Latest Research Report on LLY ## Merck & Co., Inc. (MRK) Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. - As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner Read Our Latest Research Report on MRK ## Johnson & Johnson (JNJ) Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. Read Our Latest Research Report on JNJ ## AbbVie (ABBV) AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. Read Our Latest Research Report on ABBV ## McKesson (MCK) McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. Read Our Latest Research Report on MCK ## Abbott Laboratories (ABT) Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. Read Our Latest Research Report on ABT ## Pfizer (PFE) Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. Read Our Latest Research Report on PFE ## Recommended Stories - MarketBeat's Top Five Stocks to Own in August 2026 - 2 Biotech Stocks Shaping Up for Major Breakouts - 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs - 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run - Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit? - Flash in the Pan or Sustained Rally Contender? 3 Momentum Stocks to Watch *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* Continue following MarketBeat Add MarketBeat as your preferred source on Google to see our latest stories in your feed. Add As Preferred Source ## Should You Invest $1,000 in Eli Lilly and Company Right Now? Before you consider Eli Lilly and Company, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list. While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [MRK.US](https://longbridge.com/en/quote/MRK.US.md) - [LLY.US](https://longbridge.com/en/quote/LLY.US.md) - [PFE.US](https://longbridge.com/en/quote/PFE.US.md) - [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md) - [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md) - [ABT.US](https://longbridge.com/en/quote/ABT.US.md) - [MCK.US](https://longbridge.com/en/quote/MCK.US.md) - [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md) - [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md) - [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md) - [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md) - [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md) ## Related News & Research - [India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar](https://longbridge.com/en/news/297935089.md) - [Continuous glucose monitors are about to get more complicated](https://longbridge.com/en/news/297807418.md) - [Hackers claim millions of patient records stolen during data breach at healthcare giant McKesson](https://longbridge.com/en/news/297550175.md) - [McKesson Corporation $MCK Shares Purchased by Continuum Advisory LLC](https://longbridge.com/en/news/297881946.md) - [Eli Lilly Is Acquiring Merdia Biosciences for Up to $2.88 Billion. Here's What That Means for Investors.](https://longbridge.com/en/news/297565544.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**